Fathi Javad, Hashemizadeh Zahra, Dehkordi Reza Solymani, Bazargani Abdollah, Javadi Kasra, Hosseini-Nave Hossein, Hadadi Mahtab
Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Student Research Committee, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Heliyon. 2022 Aug 13;8(8):e10230. doi: 10.1016/j.heliyon.2022.e10230. eCollection 2022 Aug.
is an important human pathogen that causes various infections. Aminoglycosides are broad-spectrum antibiotics used to treat methicillinresistant (MRSA) infections. Typing of isolates by coagulase gene typing and PCR-RFLP gene is a fast and suitable method for epidemiological studies. Aim of the present study was to evaluate the resistance to aminoglycosides, staphylococcal chromosomal cassette mec (SCCmec) types, coagulation typing and PCR-RFLP gene in clinical isolates of . 192 isolates were collected from Namazi and Shahid Faghihi hospitals. Antibiotic resistance was measured by disk diffusion method and MIC was determined for gentamicin. The presence of genes encoding aminoglycoside modifying enzymes () and gene were assessed by PCR. Also the coagulase typing, PCR-RFLP gene, and SCCmec typing were performed. Out of 192 isolated isolates, 83 (43.2%) MRSA isolates were identified. In this study, a high resistance to streptomycin and gentamicin (98.7%) were observed. Among the genes, the gene was the most common. Based on the SCCmec typing, it was determined that the prevalence of SCCmec type III (45.8%) was highest. From the amplification of the gene, 5 different types were obtained. Also, in digestion of gene products by enzyme, 10 different RFLP patterns were observed. According to this study, aminoglycoside resistance is increasing among MRSA isolates. As a result, monitoring and control of aminoglycoside resistance can be effective in the treatment of MRSA isolates. Also, typing of isolates based on gene polymorphism is a suitable method for epidemiological studies.
是一种引起各种感染的重要人类病原体。氨基糖苷类是用于治疗耐甲氧西林(MRSA)感染的广谱抗生素。通过凝固酶基因分型和PCR-RFLP基因对分离株进行分型是流行病学研究的一种快速且合适的方法。本研究的目的是评估临床分离株对氨基糖苷类的耐药性、葡萄球菌染色体盒式mec(SCCmec)类型、凝固酶分型和PCR-RFLP基因。从纳马齐医院和沙希德·法吉希医院收集了192株分离株。采用纸片扩散法测定抗生素耐药性,并测定庆大霉素的最低抑菌浓度(MIC)。通过PCR评估编码氨基糖苷修饰酶()和基因的存在。同时进行凝固酶分型、PCR-RFLP基因和SCCmec分型。在192株分离的菌株中,鉴定出83株(43.2%)MRSA分离株。在本研究中,观察到对链霉素和庆大霉素的高耐药率(98.7%)。在基因中,基因最为常见。基于SCCmec分型,确定III型SCCmec的患病率最高(45.8%)。通过基因扩增,获得了5种不同类型。此外,在用酶消化基因产物时,观察到10种不同的RFLP模式。根据本研究,MRSA分离株中氨基糖苷类耐药性正在增加。因此,监测和控制氨基糖苷类耐药性对MRSA分离株的治疗可能有效。此外,基于基因多态性对分离株进行分型是流行病学研究的一种合适方法。